Archive Page 2

Testosterone nasal spray on the market despite concerns

A new testosterone booster administered through a nasal spray is now on the market, despite concerns over testosterone therapy side effects. The testosterone booster, called Natesto, joins several other testosterone therapy drugs, including gels, creams, patches and injections.

Read more about testosterone booster concerns…

New study links antidepressants to brain malformations in infants

New imaging research has linked antidepressants such as Zoloft to Chiara type 1 brain malformations in children whose mothers used the drugs during pregnancy. The brain malformations occur when cerebellum tissue extends into the spinal column and can cause headaches and balance issues severe enough to require corrective surgery.

Read more about the link between SSRIs and brain malformations…

Doctor cites misuse of testosterone at American Urological Association meeting

Testosterone booster use and misuse could be the cause of several new health problems, says University of Kansas MD Anjay Nangia. Doctor Nangia spoke at the American Urological Association about overuse of testosterone in men who may not need it, including at least 25% of males who are prescribed testosterone without undergoing clinical testing necessary to determine potential conditions requiring testosterone, such as hypogonadism.

Read more about testosterone booster complications…

Pfizer Agrees to $325 Million Neurontin Marketing Accord

Pfizer Inc. (PFE) agreed to pay $325 million to settle a lawsuit brought by health-care benefit providers who claimed the drugmaker marketed the epilepsy drug Neurontin for unapproved uses. The settlement, which needs approval from a federal judge in Boston, would end a case over claims that the company’s Parke-Davis unit schemed to market the drug for unapproved conditions as early as 1994.


Read more about the Pfizer Neurontin settlements…

Stryker lawsuits mount against hip manufacturer

Stryker Corporation is facing an increasing number of hip replacement lawsuits alleging that the company’s implants were defective and caused injuries. More than 500 Stryker lawsuits allege that the metal components of the Rejuvenate and ABG II modular hip replacements can lead to corrosion, fretting and other severe complications.

Read more about the Stryker lawsuits…

Testosterone Lawsuits Consolidated in Chicago

Abbott Laboratories (ABT) and AbbVie Inc. will face lawsuits combined in one Chicago court over claims they hid the risks of using the testosterone booster drug AndroGel. Abbott and AbbVie are both based in the Chicago area and “a significant number” of AndroGel lawsuits already are pending before U.S. District Judge Matthew Kennelly there, according to a panel of judges.

Read more about the testosterone lawsuit consolidation…

Stryker hip replacement lawsuit deadline approaching

Patients who were injured by their Stryker metal-on-metal hip replacement likely have until July 2014 to file a lawsuit against the manufacturers. The statute of limitations, or deadline for when patients have file claims, for most Stryker hip implant lawsuits is two years. Stryker Corporation issued a Stryker recall on July 6, 2012.

Read more about the Stryker lawsuit deadline…

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.